Accumulation of Microvascular Target Organ Damage in Systemic Lupus Erythematosus Patients Is Associated with

Nikolaos Koletsos1, Antonios Lazaridis1, Areti Triantafyllou1

  • 13rd Department of Internal Medicine, Papageorgiou General Hospital, Aristotle University of Thessaloniki, 56429 Thessaloniki, Greece.

PubMed

Insights

Systemic lupus erythematosus (SLE) patients show increased target organ damage (TOD) and cardiovascular (CV) risk due to microvascular dysfunction. Early detection of these microvascular alterations is crucial for managing SLE patients.

Area of Science:

  • Cardiovascular disease research
  • Autoimmune disease pathophysiology
  • Microvascular function assessment

Background:

  • Systemic lupus erythematosus (SLE) is linked to significant cardiovascular (CV) burden, including arterial stiffness and atherosclerosis.
  • Microvascular dysfunction is a key, yet understudied, factor in SLE-related CV disease.
  • The impact of cumulative target organ damage (TOD) on CV health in SLE requires further investigation.

Purpose of the Study:

  • To identify microvascular changes across various vascular beds in SLE patients.
  • To examine the association between accumulated microvascular TOD and overall CV risk.
  • To determine if Galectin-3 predicts combined microvascular TOD in SLE.

Main Methods:

  • Assessed skin microvascular reactivity using laser speckle contrast analysis.
  • Evaluated retinal microvasculature via non-mydriatic fundus camera.
  • Measured myocardial perfusion indirectly using subendocardial viability ratio and urine albumin-to-creatinine ratio (UACR).
  • Calculated CV risk with QRISK3 and measured serum Galectin-3 levels.

Main Results:

  • SLE patients exhibited impaired skin microvascular reactivity, retinal arteriolar narrowing, and higher UACR compared to controls.
  • SLE patients had elevated Galectin-3 levels, higher QRISK3 scores, and increased prevalence of microvascular dysfunction.
  • Accumulation of TOD in SLE correlated significantly with disease activity and Galectin-3 levels.

Conclusions:

  • SLE patients demonstrate a higher incidence of TOD, particularly microvascular alterations.
  • The cumulative burden of TOD is significantly associated with increased cardiovascular risk in SLE.
  • Clinicians should proactively screen for microvascular changes in SLE patients to mitigate CV risk.

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...